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Introduction
The genus Mycobacterium consists of more than 
180 species with validly published names (Parte 2014). 
Most of them are saprophytic species widely distributed 
in the environment, some of which are pathogenic to 
humans and animals, including birds (Tan et al. 2016). 
Tuberculosis caused by the Mycobacterium tuberculosis 
complex has been found in birds that had contact with 
humans. Although in most of these cases the source of 
infection was human, domestic birds not only can be 
infection vectors, but also can show symptoms typical 
of the open form of tuberculosis, which results in active 
mycobacteria release to the environment, sometimes 
for long time periods (Washko et al. 1998; Montali et al. 
2001; Steinmetz et al. 2006; Peters et al. 2007; Ledwoń 
et al. 2008; Lanteri et al. 2011). In birds, mycobacteri-
osis caused by non-tuberculous mycobacteria (NTM) 
is definitely a more common problem than tuberculo-
sis. Clinical manifestations of mycobacteriosis in birds 
include emaciation, depression and diarrhea along with 
a marked atrophy of the breast muscle. Tubercular nod-
ules can be seen in the liver, spleen, intestine and bone 
marrow. Granulomatous lesions without calcification 
are a prominent feature. The disease is rare in the well-
organized poultry sector due to improved farm prac-
tices, but occurs in backyard poultry, zoos and aviaries 
(Portaels et al. 1996; Shitaye et al. 2008; Dhama et al. 
2011; Pfeiffer et al. 2017). Mycobacterioses also pose 
a constantly and increasingly growing threat to human 
health, especially in people with weakened immu-
nity (Schitaye et al. 2008; Slany et al. 2016; Titmarsh 
2017). The mycobacteria most frequently isolated from 
birds with mycobacteriosis are Mycobacterium avium 
and Mycobacterium genavense. These bacteria are also 
a  frequent cause of disease in people infected with 
Human Immunodeficiency Virus (HIV) (Ristola et al. 
1999) or those receiving immunosuppressive treatment 
after transplantation or other systemic diseases (Tortoli 
2006; Lastours de et al. 2008; Tan et al. 2016). A study 
Drug Susceptibility of Non-tuberculous Strains of Mycobacterium Isolated
from Birds from Poland
ALEKSANDRA LEDWOŃ1, AGNIESZKA NAPIÓRKOWSKA2, EWA AUGUSTYNOWICZ- KOPEĆ2
and PIOTR SZELESZCZUK1
1 Department of Pathology and Veterinary Diagnostics, Warsaw University of Life Sciences, Warsaw, Poland
2 Department of Microbiology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
Submitted 9 June 2018, revised 16 September 2018, accepted 17 September 2018
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conducted by Garcia-Marcos et al. (2017) showed a cor-
relation between the occurrence of mycobacteriosis 
in children and their exposure to chickens. But NTM 
can also cause disease in adult immunocompetent 
patients (Piersimoni and Scarparo 2006; Santos et al. 
2014). Because backyard poultry, pet birds and synan-
thropic animals live in the immediate vicinity of 
humans, it is important to study strains with potential 
pathogenicity for humans, as well as to assess the risk 
posed by their antibiotic resistance.
Experimental
Materials and Methods
The 46 samples tested (Table I) were collected over 
ten years from 37 dead and nine live birds originating 
mainly from Warsaw (Poland) and nearby areas. In the 
necropsied birds, except for one case, when the cause 
of death was a mechanical injury, advanced mycobac-
teriosis was diagnosed as the main cause of death. From 
the necropsied animals, liver samples were collected 
for microbiological and molecular examination. Sam-
ples from living birds were taken from areas affected 
by lesions associated with the disease. In three peafowl 
with symptoms of dyspnoea, tracheal swabs were col-
lected. In two falcons, samples from abscesses local-
ized within the subcutaneous tissue of the legs were 
collected. Faecal samples were taken from canaries and 
finches. These birds came from breeding sites in which 
cases of canary death due to mycobacteriosis had been 
reported earlier. Microscopic examinations of individu-
ally collected faeces from these aviaries allowed iden-
tification of carriers. Moreover, the presence of leuko-
cytosis with neutrophilia and monocytosis confirmed 
active infection in those birds.
Identification of mycobacteria. All samples were 
stained with TB Ziehl-Neelsen KIT (QCA, Spain). 
Decontamination of clinical and dissected material 
was carried out using Sputofluol® (Merck, Germany), 
in accordance with the manufacturer’s instruction. 
An initial culture of samples was carried out for up 
to 10 weeks at 37°C on the Löwenstein-Jansen PACT 
medium (Becton Dickinson, USA) and then up to six 
weeks on Bactec MGIT 960 (Becton Dickinson, USA). 
Ornamental chickens (Gallus gallus)  8/8  8 Mycobacterium avium (8)
Indian peafowl (Pavo cristatus)  5/3  5 Mycobacterium avium (5)
Pheasants (Phasianus spp.)  5/5  4 + 1* Mycobacterium avium (5)
Turkey (Melleagris gallopavo)  1/1  1 Mycobacterium avium (1)
Red-fronted parakeet  3/3  2 Mycobacterium avium (2)
(Cyanoramphus novaezelandiae)   1 Mycobacterium xenopi (1)*
Barred parakeet (Bolborhynchus lineola)  1/1  1* Mycobacterium genavense (1)
Fischer’s lovebird (Agapornis fischeri)  1/1  1 Mycobacterium xenopi (1)
Budgerigar (Melopsittacus undulatus)  1/1  1* Mycobacterium genavense (1)
Cockatiel (Nymphicus hollandicus)  1/1  0 Mycobacterium genavense (1)
Atlantic canary (Serinus canaria)  5/5  2* Mycobacterium genavense (5)
   1** Mycobacterium xenopi (1)
Goldfinch (Carduelis carduelis)  1/1  0 Mycobacterim spp. (1)
Bengalese finch (Lonchura striata domestica)  2/2  1* Mycobacterium genavense (1)
   1 Mycobacterium spp. (1)
Common buzzard (Buteo buteo)  2/2  1 Mycobacterium avium (1)
   1* Mycobacterium genavense (1)
Peregrine falcon (Falco peregrinus)  2/2  2 Mycobacterium avium (2)
Rock pigeon (Columba livia)  3/3***  3 Mycobacterium avium (3)
Common wood pigeon (Columba palumbus)  2/2  2* Mycobacterium avium (2)
Rook (Corvus frugilegus)  2/2  2 Mycobacterium avium (2)
Total: 46 45/43 40 (46)**
Table I
Microorganisms present in the materials taken from birds with recognized mycobacteriosis.
  * Lack of growth on media for drug resistance testing
  ** In one necropsied canary coinfection with M. genavense and M. xenopi were diagnosed
*** In one case of mycobacteriosis in a pigeon flock, M. avium was isolated from 19 individuals, but as all isolates were the same 
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Positive cultures were investigated using the BD MGIT 
TBc Identification Test (TBc ID, Becton Dickinson, 
Sparks, MD), which is an immunochromatographic 
assay for a rapid discrimination between the M. tuber-
culosis complex and NTM. The TBc ID test is based 
on the detection of the antigen MPT64, one of the 
predominant proteins secreted by the M. tuberculosis 
complex strains during culture (Martin et al. 2011). The 
NTM samples were then tested using the GenoType 
Mycobacterium CM VER 2.0 test, a molecular genetic 
assay for the identification of clinically relevant myco-
bacterial species from mycobacterium contaminated 
material (Hain Lifescience GmbH, Germany).
Samples that did not grow on the Löwenstein-Jansen 
medium (Becton Dickinson, USA) were cultured onto 
the Middlebrook 7H9 (Becton Dickinson, USA) liq-
uid medium supplemented with 2 mg/l Mycobactin J 
(Allied Monitor, Fayette, USA) (Coyle et al. 1992) for 
20 weeks. Identification of samples from which no 
culture was obtained or were grown on the media with 
Mycobactin J was performed using SYBR® Green real-
time PCR specific for M. genavense. DNA isolation 
from the liver tissue or bacterial cultures was performed 
using the GeneMATRIX Tissue & Bacterial DNA Puri-
fication Kit (Eurx®, Poland), while DNA isolation from 
faeces was made using the GeneMATRIX Stool DNA 
Purification Kit (Eurx®, Poland). The chosen forward 
primer MG 25-s(GAATCCGCTGCTGCTCTG) was 
located at nucleotides 378 to 395 of a M. genavense 
hypothetical 21 kDa protein gene (Chevrier, et al. 
1999), while the backward primer MG25-as (TCAATG-
TAGTCCTGTCCGAAC) corresponded to nucleotides 
313 to 291. Real-time PCR amplification was carried 
out in a total volume of 25 µl using SG qPCR Master 
Mix (Eurx®, Poland) according to the methodology 
described by the authors earlier (Ledwoń et al. 2009).
Drug susceptibility testing. Drug susceptibility 
tests were conducted using 34 mycobacterial isola-
tes, including 31 M. avium subsp. avium and three 
Mycobacterium xenopi. Determination of susceptibil-
ity to drugs was performed by using the proportion 
method on the Löwenstein-Jensen and Middlebrook 
7H9 media (Canetti et al. 1969; Zwolska et al. 1999; 
Augustynowicz-Kopeć et al. 2003). The susceptibility 
to isoniazid, rifampicin, streptomycin, ethambutol, 
ofloxacin, capreomycin, cycloserine and ethionamide 
was tested on the Löwenstein-Jansen medium. The sus-
ceptibility to clofazimine, rifabutin and sulfamethoxa-
zole + trimethoprim was tested on the Middlebrook 
7H9 medium. The concentrations of the antibiotics 
tested were as follows: streptomycin – 4.0, 8.0 µg/ml; 
isoniazid – 0.2, 0.4 µg/ml; rifampicin – 40.0, 80.0 µg/ml; 
ethambutol 2.0, 4.0 µg/ml; ofloxacin – 2.5, 5.0 µg/ml; 
capreomycin – 40.0, 80.0 µg/ml; cycloserine – 40.0, 
80.0 µg/ml; ethionamide – 40.0, 80.0 µg/ml; clofazimine 
– 1.0, 2.0, 4.0 µg/ml; rifabutin – 0.5, 1.0, 2.0 µg/ml, and 
sulfamethoxazole + trimethoprim – 8.0, 16.0, and 
32.0 µg/ml. Resistance was defined by the growth of 
≥ 1% of a bacillary inoculum on the drug-containing 
medium compared to a drug-free control.
Results
Mycobacteriosis was found in 46 birds belonging to 
17 bird species (Table I). Gallinaceous birds were diag-
nosed with only M. avium infections, while pet birds 
were also diagnosed with M. genavense and M. xenopi 
infections. One dead canary was found to be infected 
with both M. genavense and M. xenopi. In wild birds, 
M. avium predominated, although M. genavense was 
found in one buzzard. Positive Ziehl-Neelsen staining 
(AFB +) was observed in 43 cases analysed. The growth 
of bacterial colonies on the Löwenstein-Jensen and 
Bactec MGIT 960 media was noticed for 34 samples 
collected. 31 isolates of M. avium and three isolates of 
M. xenopi were cultured. Drug susceptibility was tested 
for 28 M. avium and three M. xenopi strains (Table II 
and Table III). M. avium strains from common pheas-
ant (Phasianus colchicus) and wood pigeons (Columba 
palumbus) did not demonstrate any growth on the 
media used for the assessment of drug resistance. Ten 
samples were identified as M. genavense, five of which 
were cultured on the Middlebrook 7H9 medium with 
Susceptible 8 0 0 0 20 0 25 3 8 27 10
Moderately susceptible 0 0 0 0 0 0 0 0 10 0 0
Moderately resistant 0 0 0 0 0 0 0 0 6 0 8
Resistant 4 28 28 28 5 28 2 0 4 1 10
No data** 16 0 0 0 3 0 1 25 0 0 0
Table II
Drug resistance of 28 strains of M. avium isolated from birds.
* SM – streptomycin, RFP – rifampicin, INH – isoniazid, EMB – ethambutol, CPM – capreomycin, OFLOX – ofloxacin, CS – cycloserine,
 ETH – ethionamide, SXT – sulfamethoxazole + trimethoprim, CFM – clofazimine, RIF – rifabutin
** Number of strains which did not demonstrate any growth on the media used for the assessment of drug resistance
Drug* SM OFLOXCPMEMBRFPINH CS RIFSXTETH CFM
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Mycobactin J. Two samples were identified as Mycobac-
terium spp. These mycobacteria were also incapable of 
growing on the medium for susceptibility testing.
Discussion
M. avium and M. genavense have been the main 
causes of mycobacterioses described to date in birds 
(Tell et al. 2001; Shivaprasad and Palmieri 2012; Pfeffer 
et al. 2017). Our study confirmed the results published 
by other authors. Mycobacterioses caused by M. xenopi 
are very rarely diagnosed in birds (St-Jean et al. 2018). In 
our investigations, even though only three isolates were 
obtained, it should not be underestimated. M. xenopi 
has recently been isolated from water (Slozarek et al. 
1993) which is also a source of infection for humans 
and animals. Birds that were diagnosed with this bacte-
rial infection, however, came from various breeders, so 
it could not be concluded that they infected themselves 
with the same water intake.
M. genavense is very difficult to be cultured on the 
media, and its diagnostics are mainly based on molec-
ular methods (Hoop et al. 1993; Portaels et al. 1996; 
Ledwoń et al. 2009; Palmieri et al. 2013). Therefore, 
the drug susceptibility tests used in this study may not 
be useful for testing of these mycobacteria. Strains of 
M. avium (Table II) demonstrated 100% resistance to 
isoniazid, rifampicin and ethambutol, while strains 
tested on ethionamide showed a good susceptibility to 
that antibiotic. These results differ from those described 
in a study by Parvandar et al. (2016) in which all 
M. avium strains isolated from pigeons for drug suscep-
tibility tests were shown to be resistant to streptomycin, 
kanamycin, ethionamide and thiophene carboxylic acid 
hydrazide. Moreover, single isolates were susceptible to 
isoniazid, rifampicin and ethambutol (Parvandar et al. 
2016). In the cases described by Stepień-Pyśniak et al. 
(2016), M. avium strains isolated from birds demon-
strated resistance to isoniazid, rifampicin, ethambutol, 
ethionamide, capreomycin and ofloxacin, and were sus-
ceptible to streptomycin and cycloserine. M. xenopi iso-
lated from birds (Table III) presented resistance similar 
to that of isolates originating from humans (van Ingen 
et al. 2010). These isolates were resistant to isoniazid, 
slightly less resistant to rifampicin and ethambutol, and 
fully susceptible to other antibiotics. All three species 
of mycobacteria identified from the cases of mycobac-
teriosis in birds are able to cause mycobacteriosis in 
humans, particularly in immunocompromised hosts 
(Coyle et al. 1992; Ristola et al. 1999; Bluth et al. 2009; 
Shah et al. 2016; Adzic-Vukicevic et al. 2018). Therefore, 
mycobacterioses in birds living in a direct proximity 
to humans should be taken seriously, since they can 
constitute a potential reservoir of infection with myco-
bacteria resistant to multiple antimycobacterial drugs.
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